When researchers aim to understand how medications or treatments influence living systems, they often face complex scientific and ethical considerations (Shelar et al, 2023). In an earlier article, we explored
in vivo research – studies carried out within a living organism. In vivo methods involve whole organisms such as humans, laboratory animals, or plants (Dornell, 2023; Eske, 2023) and allow researchers to observe biological processes as they naturally occur (Shelar et al, 2023). In many cases, in vivo experiments help determine the initial safety and effectiveness of new treatments before they progress to human trials (Dornell, 2023; Shelar et al, 2023). However, these studies can be time-intensive and costly, and they do not always accurately reflect the complex processes that occur in the human body (Xu et al, 2021).
Another important approach is ex vivo research. This method examines biological tissue that has been removed from an organism but maintained in conditions that preserve its normal function (Shelar et al, 2023). The term ‘ex vivo’ literally means ‘out of the living’. In these studies, tissues, cells, or even organs are kept viable, often using nutrient solutions or specialised perfusion systems, to allow researchers to investigate how they respond to various interventions (Xu et al, 2021).
Both in vivo and ex vivo methods are widely used to advance understanding of human diseases and to support the development of new therapies (Shelar et al, 2023).
Ex vivo techniques serve as a bridge between simple cell cultures and complex animal models (Kapila et al, 2017).Because intact tissues are used, this approach can capture biological responses that are more realistic than standard cell culture, while still offering the controlled environment of a laboratory (Xu et al, 2021; Shelar et al, 2023). This helps fill knowledge gaps that arise when using only one type of model.